GHK-Cu and AHK-Cu are two copper-binding tripeptides. They are closely related, but they are not the same compound and should not be treated as interchangeable research materials. They have different sequences.
- GHK-Cu contains the sequence glycyl-histidyl-lysine (GHK).
- AHK-Cu contains alanyl-histidyl-lysine (AHK).
The two differ at the first amino acid, and their published research profiles are also different. GHK-Cu has a much larger body of research, while AHK-Cu has been studied more narrowly, particularly in hair-follicle and dermal-papilla models.
Research Use Only: This article discusses GHK-Cu and AHK-Cu as research compounds. The information below is intended for laboratory and scientific research and should not be interpreted as medical or therapeutic guidance.
What Are Copper Peptides?
Copper peptides are peptide molecules that form complexes with copper ions. One of the best-known examples is GHK-Cu, the copper complex of glycyl-L-histidyl-L-lysine.
GHK itself is a naturally occurring tripeptide that has been detected in human plasma. It has a strong affinity for copper and can form the GHK-Cu complex. Research has investigated GHK-Cu in areas including extracellular matrix biology, inflammation, oxidative processes, and tissue remodeling.
AHK-Cu is a related copper-binding tripeptide. Its peptide sequence is alanyl-L-histidyl-L-lysine, meaning alanine replaces glycine at the first position.
That single amino acid substitution makes AHK-Cu chemically distinct from GHK-Cu.
GHK-Cu vs AHK-Cu: What Is the Major Difference?
The easiest way to understand the difference is to compare their sequences:
| Feature | GHK-Cu | AHK-Cu |
| Peptide sequence | Gly-His-Lys | Ala-His-Lys |
| First amino acid | Glycine | Alanine |
| Copper complex | Cu(II) | Cu(II) |
| Relationship | Reference copper tripeptide | Structural analogue of GHK-Cu |
| Research literature | Present | Limited |
| Major research areas | Matrix, skin, cellular and tissue models | Hair-follicle and dermal-papilla models |
| Direct head-to-head research | Not established | Not established |
There is a small structural difference between glycine and alanine, but researchers should still treat the compounds as separate molecules.
Importantly, evidence obtained with GHK-Cu should not automatically be attributed to AHK-Cu, or vice versa.
What Is GHK-Cu?
GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine.
GHK was identified as a naturally occurring peptide in human plasma, and its capacity to bind copper has been the subject of biochemical and cellular research for decades. A 2021 review summarized research on GHK and GHK-Cu, including their roles in tissue remodeling, inflammation, antioxidant activity, and cellular signaling. More recent reviews have characterized GHK-Cu as a research subject with considerable pre-clinical literature and, as yet, limited and heterogeneous clinical evidence.
For research purposes, GHK-Cu, therefore, may be relevant to questions of:
- Extracellular-matrix biology
- Fibroblast-related processes
- Collagen-associated pathways
- Cellular signaling
- Oxidative and inflammatory pathways
- Copper-peptide chemistry
This is not to suggest any therapeutic effects — merely that research into these areas may include GHK-Cu.
What Is AHK-Cu?
AHK-Cu is the copper complex of L-alanyl-L-histidyl-L-lysine.
Its primary distinguishing feature is the substitution of alanine for the glycine found in GHK-Cu.
The direct AHK-Cu literature is considerably smaller than the GHK-Cu literature. One frequently-cited study investigated the effects of AHK-Cu on human hair follicles held ex vivo and cultured dermal papilla cells. The researchers observed an increase in hair-follicle elongation and dermal papilla cell proliferation under the experimental conditions.
The study also investigated apoptosis-related markers in dermal papilla cells. This is a laboratory foundation for further investigation, but it does not represent a clinical effect in humans.
How Does the Research on GHK-Cu Differ From AHK-Cu?
The key difference is the quantity and quality of the research evidence.
GHK-Cu has been investigated in dozens of studies in various experimental models, including cell culture, animals, isolated human tissues, and even patients (although with varying degrees of relevance and quality of evidence). More recent reviews note a decline in research on the peptide, but it remains popular among researchers.
On the other hand, the direct AHK-Cu literature is considerably smaller, with the 2007 study providing important evidence from human hair-follicle and dermal-papilla models.
Therefore, the two compounds have different levels of evidence of efficacy. Consequently, extrapolating the effects of one substance to another based on the similarity of their structures is not an appropriate approach.
GHK-Cu vs AHK-Cu for Hair-Follicle Research
AHK-Cu has attracted particular interest in hair-follicle research because of the 2007 study involving human hair follicles and dermal papilla cells.
In that study, AHK-Cu was tested at concentrations ranging from 10⁻¹² to 10⁻⁹ M. The researchers reported stimulation of hair-follicle elongation ex vivo and proliferation of dermal papilla cells in vitro.
However, this was not a clinical trial.
The experiment involved laboratory models rather than participants receiving AHK-Cu. Therefore, the findings should be described as preclinical or ex vivo evidence.
GHK-Cu has also appeared in research involving hair and skin biology, but its broader research profile includes extracellular matrix and cellular studies beyond hair-follicle models.
Does AHK-Cu Have the Same Evidence as GHK-Cu?
No.
This is one of the most important points when comparing these compounds.
Because AHK-Cu and GHK-Cu share a similar copper-binding peptide structure, it can be tempting to assume that research on one applies equally to the other.
That assumption is not justified.
Available research reviews indicate that there is no established controlled head-to-head study directly comparing GHK-Cu and AHK-Cu under matched experimental conditions. Their evidence bases instead come from separate experiments using different models, concentrations, endpoints, and study designs.
Consequently, researchers should evaluate the evidence for each compound independently.
Why Does the One-Amino-Acid Difference Matter?
Glycine and alanine are both small amino acids, but they are not identical.
Glycine has a hydrogen atom as its side chain, whereas alanine has a methyl group.
Therefore:
GHK: Gly-His-Lys
AHK: Ala-His-Lys
The histidine and lysine residues remain the same, but changing the first residue changes the chemical structure of the peptide.
For copper-binding peptides, small structural differences can influence molecular properties and interactions with copper. However, researchers should avoid assuming that a structural difference automatically produces a specific biological outcome unless experimental data demonstrate it.
GHK-Cu vs AHK-Cu: What Should Researchers Compare?
If a study requires comparing these two copper peptides, researchers should consider several analytical and experimental variables.
1. Peptide Identity
Confirm that the material is actually the intended peptide.
GHK-Cu and AHK-Cu should be treated as separate research compounds because their amino acid sequences differ.
2. Purity
Review the supplier’s reported purity and the analytical method used to determine it.
HPLC can provide chromatographic purity information, while mass spectrometry can provide molecular-mass information useful for identity confirmation.
3. Copper Complexation
Because these are copper-peptide complexes, researchers should consider whether the analytical documentation adequately characterizes the material’s copper-associated form.
The chemical state of copper-containing peptide preparations can be more complicated than simply reporting a peptide purity percentage. Recent GHK-Cu literature has specifically highlighted the importance of distinguishing peptide identity, copper occupancy, formulation, and chemical speciation.
4. Experimental Model
Results from fibroblasts, dermal papilla cells, whole follicles, animal models, and other systems should not be treated as equivalent.
The biological model is part of the evidence.
5. Concentration
Concentration is another important variable. Findings observed at a particular concentration in an in vitro experiment should not automatically be extrapolated to other experimental systems.
6. Controls
A meaningful comparison should use appropriate controls and, where relevant, distinguish the effects of the peptide from those associated with copper itself or the experimental formulation.
Which Copper Peptide Should Researchers Choose?
There is no scientifically established answer that one compound is universally preferable to the other.
The appropriate choice depends on the research question, experimental model, analytical requirements, and available evidence.
GHK-Cu may be relevant to research programs investigating its broader biochemical and cellular literature. AHK-Cu may be of interest when specifically investigating the experimental questions surrounding AHK-Cu, including hair-follicle and dermal-papilla models.
The important point is to select the compound based on the specific research question, rather than assuming that GHK-Cu and AHK-Cu are interchangeable.
How Should Researchers Evaluate a GHK-Cu or AHK-Cu Supplier?
When purchasing either copper peptide for laboratory research, review the available documentation.
Look for:
- Batch-specific Certificate of Analysis
- Peptide identity information
- HPLC purity data
- Mass spectrometry data
- Batch or lot number
- Testing date
- Testing laboratory information
- Quantity or content information where applicable
- Storage and handling information
- Clear research-use labeling
A high advertised purity percentage alone does not establish every aspect of material quality.
For copper-containing peptides, researchers should also consider whether the supplier provides enough information to distinguish the peptide identity from the copper-complexed material.
Research Gap: GHK-Cu vs AHK-Cu
One of the clearest gaps in the literature is the lack of a robust direct comparison between GHK-Cu and AHK-Cu.
Existing studies generally investigate one compound at a time and use different experimental systems. A properly controlled comparative study could examine both compounds under matched conditions and evaluate:
- Copper-binding characteristics
- Stability
- Cellular uptake
- Concentration-response relationships
- Molecular signaling
- Effects across relevant cell models
- Structure-function relationships
Until such studies are available, claims that one compound is definitively more effective than the other should be treated cautiously.
FAQs
1. Are GHK-Cu and AHK-Cu the same peptide?
No. GHK-Cu contains Gly-His-Lys, while AHK-Cu contains Ala-His-Lys. They are structurally related copper-binding tripeptides but are distinct compounds.
2. What is the main difference between GHK-Cu and AHK-Cu?
The first amino acid differs. GHK-Cu has glycine, while AHK-Cu has alanine. Their published research profiles also differ substantially.
3. Is AHK-Cu the same as GHK-Cu for research purposes?
No. Findings from one compound should not automatically be applied to the other. Direct head-to-head evidence is currently lacking.
4. What has AHK-Cu been studied for?
A notable study investigated AHK-Cu using human hair follicles maintained ex vivo and cultured dermal papilla cells.
5. Which has more published research?
GHK-Cu has a substantially larger and broader research literature than AHK-Cu. Recent reviews continue to describe extensive preclinical research on GHK-Cu, while the direct AHK-Cu literature remains limited.
6. Are GHK-Cu and AHK-Cu FDA-approved treatments?
This article discusses them as research compounds. Research evidence should not be interpreted as FDA approval or evidence of an approved therapeutic use.
Conclusion
Although GHK-Cu and AHK-Cu are closely related copper-binding tripeptides, this does not mean that they are entirely similar. Both tripeptides have a broad range of reported effects, but GHK-Cu was discovered earlier and has more extensive research dating back several decades, while AHK-Cu’s main area of research is connected to hair follicles and dermal papilla cells. Therefore, the most important difference between the two is the volume and quality of evidence. The results of studies and experiments conducted on GHK-Cu cannot be carelessly transferred to AHK-Cu, and their comparison should be based only on the available data.
In this way, it would be interesting to see the results of experiments that would directly compare the two similar but different copper peptides and analyze their chemical properties, stability, cellular effects, and contribution to research.